Overall survival of AML patients with trisomy 8 as a sole abnormality, those with trisomy 8 as part of a complex karyotype with 3 or more abnormalities, and patients with trisomy 8 accompanied by, respectively, t(8;21), inv(16)/t(16;16), t(9;11), and 1 additional abnormality other than the aforementioned ones.